Bayer’s Kerendia approved in the US to slow CKD in type 2 diabetes patients

14th July 2021 Uncategorised 0

The approval is based on data from the Phase III FIDELIO-DKD renal outcomes study

More: Bayer’s Kerendia approved in the US to slow CKD in type 2 diabetes patients
Source: News